comprehensive -WSS

comprehensive

author：comprehensive 2025-10-02 12:01:38 - browse：23

Principal Deputy FDA Commissioner Janet Woodcock Stefani Reynolds/The New York Times via AP

WASHINGTON — Principal Deputy FDA Commissioner Janet Woodcock will retire early next year from the Food and Drug Administration after helping steer the agency through an historic period of medical advances during nearly four decades in key leadership positions, she confirmed to STAT Thursday.

Woodcock, a doctor with a chemistry degree, joined FDA in 1986 at its biologics center, where she oversaw the approval of the first biotechnology-based treatments for multiple sclerosis and cystic fibrosis. In 1994, she was named director of the drug center, where she played a key role in guiding some of the most impactful changes to the regulation of medicine, according to Trump administration FDA Commissioner Scott Gottlieb.

Woodcock envisioned that antibody drugs would become a backbone of therapy and created a more predictable regulatory path for their review and approval, Gottlieb said. She presided over a major expansion and modernization of the generic drug program, standardizing reviews in a way that allowed the industry to become safer and more robust, and crafted the reform of over-the-counter drug reviews.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Stroke rates rising, especially in working

leisure time

WSS

In utero gene editing: an explainer

Medicare inequities exacerbate Puerto Rico’s health disparities

Congress: Prevent baby formula shortages by passing a new bill

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Some medical students still think black patients feel less pain

Alabama frozen embryo ruling has major implications for IVF clinics

knowledge

comprehensive

hotspot

Heart attack and stroke risk calculators need revising

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Novavax promises a turnaround & Lilly roils the obesity market

R1 RCM gets $5.8 billion buyout offer from private equity firm

Guidelines to prevent youth baseball injuries need more muscle

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Jerome Adams on the need for new antivirals for Covid

NIH study of ME/CFS points to clear biological hallmarks

Cancer drug shortages should be causing more outrage

Why palliative psychiatry is worth discussing

leisure time

Protect nursing home residents from future pandemics

A solution to the after

NIH study of ME/CFS points to clear biological hallmarks

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Wikipedia

focus

leisure time

hotspot